Back
NioCorp Developments Vs. Halozyme Therapeutics Industry Stock Comparison
Sell
19
NB
NioCorp Developments
Last Price:
1.75
Seasonality Move:
4.49%
Sell
30
HALO
Halozyme Therapeutics
Last Price:
52.16
Seasonality Move:
20.13%
Sell
19
NioCorp Developments (NB)
is a Sell
Is NioCorp Developments a Buy, Sell or Hold?
- The current NioCorp Developments [NB] share price is $1.72. The Score for NB is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- NB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $50.65. The Score for HALO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NB Stock Price Chart
What is NioCorp Developments's stock price today?
-
The NioCorp Developments share price today is $1.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NB is experiencing slight buying pressure.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $50.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
NB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 43.71 | Sell |
| Chaikin Money Flow: | 37407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.67 - 1.93) | Sell |
| Bollinger Bands (100): | (1.7 - 2.1) | Sell |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.4 | Sell |
| Relative Strength Index (14 RSI): | 30.8 | Sell |
| Chaikin Money Flow: | -1825954 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.62 - 61.32) | Sell |
| Bollinger Bands (100): | (49 - 60.08) | Sell |
NB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.84 | Sell |
| 20-day SMA: | 1.81 | Sell |
| 50-day SMA: | 1.83 | Sell |
| 200-day SMA: | 2.32 | Sell |
| 8-day EMA: | 1.79 | Sell |
| 20-day EMA: | 1.82 | Sell |
| 50-day EMA: | 1.85 | Sell |
| 200-day EMA: | 2.45 | Sell |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.28 | Sell |
| 20-day SMA: | 58.18 | Sell |
| 50-day SMA: | 58.64 | Sell |
| 200-day SMA: | 46.49 | Buy |
| 8-day EMA: | 55.36 | Sell |
| 20-day EMA: | 57.29 | Sell |
| 50-day EMA: | 57.37 | Sell |
| 200-day EMA: | 49.67 | Buy |
NioCorp Developments Earnings Growth & NB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.09 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $0.79 per share.
NioCorp Developments Technical Analysis
| Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics Technical Analysis
| Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||